Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9883735 | 0.96 | ALDH1A1 (0.37) | ALDH1A1LMNAEGLN1FFAR3HDAC3 | |
| SCHEMBL10911455 | 0.85 | NAALAD2 (0.34) | BLMPMP22HSD17B10ALDH1A1LMNA | |
| SCHEMBL15222424 | 0.83 | TSHR (0.37) | BLMPMP22HSD17B10ALDH1A1LMNA | |
| SCHEMBL8932043 | 0.82 | ALDH1A1 (0.37) | PMP22ALDH1A1LMNAEGLN1FFAR3 | |
| SCHEMBL439265 | 0.82 | ALDH1A1 (0.37) | ALDH1A1LMNAEGLN1FFAR3HDAC3 | |
| SCHEMBL25565623 | 0.81 | THRB (0.30) | THRB | |
| SCHEMBL25890697 | 0.81 | THRB (0.30) | THRB | |
| SCHEMBL16134189 | 0.81 | LMNA (0.50) | BLMPMP22HSD17B10ALDH1A1LMNA | |
| SCHEMBL351356 | 0.81 | LMNA (0.50) | BLMPMP22HSD17B10ALDH1A1LMNA | |
| SCHEMBL22771166 | 0.81 | LMNA (0.50) | BLMPMP22HSD17B10ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040723-B2 | Method of synthesizing a substantially monodispersed mixture of oligomers | BIOCON LIMITED (IN) | 2015-05-26 | — | — | US | disclosed |
| US-20110118480-A1 | METHOD OF SYNTHESIZING A SUBSTANTIALLY MONODISPERSED MIXTURE OF OLIGOMERS | BIOCON LIMITED (IN) | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118480-A1 | METHOD OF SYNTHESIZING A SUBSTANTIALLY MONODISPERSED MIXTURE OF OLIGOMERS | PARG, NOP58, NUP205 | BLM 70/4885PMP22 75/4885HSD17B10 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.